Somebody has told you that your gut bacteria are "out of balance". It is one of those phrases that sounds like an explanation and turns out, when you press on it, to contain almost nothing. Out of balance how? Which bacteria? And if a shelf of probiotics can fix it, why did the ones you bought do so little?
You deserve the actual answer, because the microbial shift in Crohn's disease is specific, it is measurable, and it explains several things about your treatment history that nobody has explained to you.
Change one: the ecosystem gets thinner
The single most reproducible finding in Crohn's disease is a loss of microbial diversity. Fewer distinct species, and a community dominated by fewer of them.
Diversity is not a wellness slogan. It is what makes an ecosystem stable. A gut community with many members has redundancy — several different organisms performing the same protective job, so the loss of one is absorbed. Strip that out and the whole community becomes brittle: an antibiotic course, a stomach bug, a bad month of eating, and the population swings hard.
If your disease has ever seemed to flip from stable to flaring on the smallest provocation, this is part of the reason. You are not fragile. Your microbial ecosystem is.
Change two: you lose the bacteria that feed your gut wall
This is the change that matters most, and it is where the microbiome stops being an abstraction and starts being your symptoms.
A specific group of your gut bacteria ferment dietary fibre and produce short-chain fatty acids, chief among them butyrate. In Crohn's disease these butyrate producers are consistently depleted — and this is not a trivial loss, because butyrate does two jobs your bowel cannot do without.
It is the fuel. The cells lining your colon are unusual: they do not run primarily on glucose from your bloodstream. They run on butyrate produced right next to them by bacteria. Starve those cells of butyrate and the barrier they form weakens — not because of anything the immune system did, but because the cells maintaining it are underpowered.
It is a brake on inflammation. Butyrate helps drive the development of regulatory immune cells in the gut wall — the ones whose entire function is to say stand down, this is not a threat. Lose butyrate and you lose one of the immune system's most important restraining signals, in precisely the tissue that most needs it.
So the loss of a bacterial group simultaneously starves the barrier and releases the brake on the immune response. That combination is the engine of the disease.
Change three: something worse moves in
Ecological vacuums do not stay empty. As the protective, fibre-fermenting organisms retreat, others expand into the space they leave — organisms that tolerate inflammation and oxygen far better, because an inflamed gut surface is chemically a different habitat from a healthy one.
Among these are adherent-invasive strains — bacteria that do not merely pass through, but attach to receptors on the intestinal lining, cross into the tissue, and survive inside the very immune cells sent to destroy them. They persist there and continue to drive inflammatory signalling from within.
This is the point at which the microbiome stops being a bystander and becomes a driver. Inflammation creates the conditions these strains prefer. These strains then generate more inflammation. The gut becomes an environment that actively selects for the organisms that harm it.
Why antibiotics help — and then leave you worse
Now your treatment history makes sense.
Antibiotics genuinely help in Crohn's disease. They reduce bacterial load, they are valuable against abscesses and complicating infection, and patients often feel real relief. That relief is not imaginary, and prescribing them is not a mistake.
But look at what an antibiotic actually does to the ecosystem described above.
It reduces diversity — the exact quality that was already depleted. It hits the sensitive, fibre-fermenting, butyrate-producing organisms hard, because those are precisely the delicate specialists that broad-spectrum agents remove most easily. The hardier, inflammation-tolerant organisms that were already expanding survive relatively better, and after the course ends they recolonise the emptied territory faster than the specialists can return.
So you feel better for a while, and the substrate underneath you gets worse. The community is thinner, the butyrate supply is lower, the barrier is more poorly fed, and the ground is more hospitable to the invasive strains than it was before. Recurrence, when it arrives, tends to arrive at greater intensity.
That is not a failure of the drug or the doctor. It is the predictable arithmetic of removing bacteria without changing the conditions that select which bacteria return.
And why probiotics alone rarely hold
The same arithmetic explains the supplement drawer.
Seeding beneficial organisms into an inflamed, permeable, low-fibre-fermentation gut is planting into hostile ground. The species you are introducing need a mucus layer to colonise, fermentable substrate to eat, and a non-inflamed surface to survive on. In active Crohn's disease, none of the three is reliably present.
You cannot repopulate a terrain you have not corrected. That is why microbial restoration is not a first move in our protocol — it is a second one.
Where microbiome repair actually sits in the sequence
EPOH follows the LIFES protocol, and its order is clinically non-negotiable.
Phase L — Lowering the Load (4–8 weeks). Oral Inflammatory Load Reduction formulations reduce the accumulated inflammatory load (Ama). This comes first, including here — because inflammation is what makes the gut surface habitable for the wrong organisms. Reduce it and you begin to change the selection pressure itself.
Phase I — Internal Healing (8–16 weeks). Now microbiome repair, alongside gut lining integrity and immune recalibration, using Internal Correction formulations. The same work attempted in week one would have been planting into a field on fire.
Phase F — Functional Clearance (6–12 weeks, usually concurrent with I). Oral formulations supporting internal clearance capacity. It is never brought forward: applied before L and I are stable, it mobilises internal load faster than the body can clear it and makes the condition worse.
Phase E — External Care. Topical External Tissue Repair formulations, applied by you at home.
Phase S — Sustaining Remission (6–12 months). Tapered Remission Maintenance formulations and monitoring — because a microbial community that has just been rebuilt is, for a long while, still a young one.
All of it is formulation-based, compounded to your driver profile. There is no procedure at any stage and no clinic visit at any stage; everything is couriered to you.
Timelines, and what we will not promise
Microbial communities re-establish over months, not days. Recovery Stage 1 — Internal Shift — runs weeks 1–4 and is quiet. Expect the Partial Improvement Plateau in weeks three to six, when early gains stall; it is the signal that Phase L is done and Phase I must begin, not a sign of failure. Recovery Stage 2 brings reduced frequency (months 2–4), Recovery Stage 3 reduced severity (months 4–8), Recovery Stage 4 stable remission (months 8+).
If you have established fibrotic stricturing or extensive structural bowel damage, restoring the microbial environment will not reverse scar tissue, and full remission may not be achievable. We would rather say this at assessment than let you discover it.
Keep taking what you have been prescribed
Nothing here is a reason to stop a medication — including antibiotics your gastroenterologist has prescribed for a specific, current indication. You start EPOH while continuing your prescriptions as written. As internal correction takes effect, medication is reviewed with your prescribing physician, and any reduction is gradual and structured.
Next
The rest of this cluster lives in our Crohn's disease hub, including the article on the self-sustaining loop between your gut barrier and your immune system, which is the loop your microbiome sits inside.
If you want your own driver profile mapped, consultations are by video or WhatsApp, and formulations are couriered to your address. There is no procedure and no clinic visit at any stage.
